eCTD Guidance for Marketing Authorisation and Post-Authorisation Applications in Europe: A 2026 Regulatory Perspective
Most of the regulatory processes in Europe are required to submit Electronic Common Technical Document (eCTD). Standardized electronic dossiers are required by the European Medicines Agency (EMA) and national competent authorities of the Marketing Authorisation Application (MAA) and the Post-Authorisation Application (PAA). It is necessary to know the latest guidance to make submissions and manage lifecycles successfully.
eCTD for Marketing Authorisation Applications (MAA)
Marketing Authorisation Applications are the initial formal applications that are submitted as requests to approve a medicinal product to be marketed in Europe. The EMA requires the presentation of all MAAs, whether by centralized, decentralized or mutual recognition procedure, to be presented in the form of eCTD.
Key requirements include:- Use of the latest EU Module 1 specification (currently v3.1.1)
- Proper organization of Modules 1–5
- Accurate XML backbone and metadata
- Compliance with current validation criteria
- EMA
- BfArM
- ANSM
require strict adherence to these standards. Any technical validation errors can lead to rejection before scientific review even begins.
eCTD for Post-Authorisation Applications (PAA) Post-authorisation activities involve maintaining and updating approved products throughout their lifecycle. These include:
- Variations (Type IA, IB, II)
- Renewals
- Line extensions
- Safety updates
Each submission must follow the eCTD lifecycle model, ensuring correct use of sequence numbers, related sequences, and lifecycle operators (replace, append, delete).
European health authorities, including:- MHRA
- AIFA
expect consistency between initial MAA submissions and subsequent updates. Mismanagement of lifecycle sequences is one of the most common causes of delays.
Key Challenges in MAA & PAA eCTD Submissions- Managing complex lifecycle sequences
- Adapting to frequent EMA guideline updates
- Ensuring validation compliance (v8.x)
- Coordinating multi-country submissions
- End-to-end eCTD publishing and submission
- Automated validation aligned with EMA requirements
- Lifecycle management for variations and renewals
- Expert regulatory consulting for EU procedures
With the regulatory demands ever changing, firms are expected to embrace efficient systems and professional assistance to handle initial and post approval submissions. Masuu Global understands the European regulations in and out, thus making it easy to submit eCTDs in a compliant and efficient manner in all requirements of product lifecycle.